ISHARES TR's ticker is HDV and the CUSIP is 46429B663. A total of 310 filers reported holding ISHARES TR in Q4 2016. The put-call ratio across all filers is 0.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $364,410 | -1.9% | 3,685 | 0.0% | 0.06% | +7.3% |
| Q2 2023 | $371,411 | -0.9% | 3,685 | 0.0% | 0.06% | -3.5% |
| Q1 2023 | $374,617 | +97456.5% | 3,685 | 0.0% | 0.06% | -8.1% |
| Q4 2022 | $384 | -99.9% | 3,685 | -11.7% | 0.06% | -25.3% |
| Q3 2022 | $381,000 | -4.0% | 4,172 | +5.6% | 0.08% | -3.5% |
| Q2 2022 | $397,000 | -7.0% | 3,952 | -1.1% | 0.09% | +3.6% |
| Q1 2022 | $427,000 | +6.0% | 3,995 | 0.0% | 0.08% | -11.7% |
| Q4 2021 | $403,000 | +6.9% | 3,995 | 0.0% | 0.09% | -3.1% |
| Q3 2021 | $377,000 | -2.3% | 3,995 | 0.0% | 0.10% | -64.2% |
| Q2 2021 | $386,000 | +2.9% | 3,995 | +1.1% | 0.27% | +0.4% |
| Q1 2021 | $375,000 | +8.4% | 3,952 | 0.0% | 0.27% | -1.1% |
| Q4 2020 | $346,000 | -25.9% | 3,952 | -31.9% | 0.27% | -30.5% |
| Q3 2020 | $467,000 | -3.9% | 5,799 | -3.1% | 0.39% | -14.9% |
| Q2 2020 | $486,000 | +13.6% | 5,986 | 0.0% | 0.46% | -2.1% |
| Q1 2020 | $428,000 | -31.6% | 5,986 | -6.3% | 0.47% | -14.2% |
| Q4 2019 | $626,000 | +4.2% | 6,386 | 0.0% | 0.55% | -3.2% |
| Q3 2019 | $601,000 | -2.0% | 6,386 | -1.5% | 0.57% | +0.7% |
| Q2 2019 | $613,000 | +1.3% | 6,486 | 0.0% | 0.56% | +59.8% |
| Q1 2019 | $605,000 | +9.6% | 6,486 | -0.9% | 0.35% | +15.0% |
| Q4 2018 | $552,000 | -21.3% | 6,546 | -15.5% | 0.31% | -2.8% |
| Q3 2018 | $701,000 | -0.3% | 7,746 | -6.4% | 0.32% | -1.9% |
| Q2 2018 | $703,000 | +0.6% | 8,276 | 0.0% | 0.32% | +24.8% |
| Q1 2018 | $699,000 | -6.3% | 8,276 | 0.0% | 0.26% | -16.2% |
| Q4 2017 | $746,000 | +4.6% | 8,276 | -0.3% | 0.31% | -21.4% |
| Q3 2017 | $713,000 | -0.8% | 8,301 | -4.0% | 0.39% | +18.1% |
| Q2 2017 | $719,000 | -0.8% | 8,651 | 0.0% | 0.33% | +0.9% |
| Q1 2017 | $725,000 | +1.8% | 8,651 | 0.0% | 0.33% | -9.1% |
| Q4 2016 | $712,000 | 0.0% | 8,651 | -1.3% | 0.36% | +16.0% |
| Q3 2016 | $712,000 | -6.3% | 8,764 | -5.3% | 0.31% | +7.6% |
| Q2 2016 | $760,000 | +5.3% | 9,252 | 0.0% | 0.29% | -12.1% |
| Q1 2016 | $722,000 | -99.9% | 9,252 | +11.4% | 0.33% | +17.0% |
| Q4 2015 | $609,450,000 | +77045.6% | 8,302 | -26.9% | 0.28% | -37.1% |
| Q3 2015 | $790,000 | +58.0% | 11,361 | +67.1% | 0.45% | +43.6% |
| Q2 2015 | $500,000 | – | 6,797 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVS HEALTH Corp | 624,536 | $62,722,000 | 52.01% |
| Angeles Investment Advisors, LLC | 2,162,920 | $217,222,000 | 19.86% |
| Bull Oak Capital, LLC | 162,500 | $16,320,000 | 15.09% |
| Essex Private Wealth Management, LLC | 38,182 | $3,835,000 | 14.33% |
| VAUGHAN & Co SECURITIES, INC. | 145,498 | $14,612,000 | 11.71% |
| SWISS RE LTD | 564,820 | $56,725,000 | 11.35% |
| Rain Capital Management, LLC | 133,852 | $13,443,000 | 9.66% |
| Titus Wealth Management | 189,826 | $19,064,000 | 9.55% |
| MCIA Inc | 182,506 | $18,400,000 | 9.20% |
| Prostatis Group LLC | 55,911 | $5,615,175 | 8.75% |